FERLAZZO, GUIDO
 Distribuzione geografica
Continente #
EU - Europa 9.984
AS - Asia 412
SA - Sud America 59
NA - Nord America 47
AF - Africa 10
Totale 10.512
Nazione #
IT - Italia 9.978
SG - Singapore 174
CN - Cina 127
VN - Vietnam 88
BR - Brasile 44
US - Stati Uniti d'America 40
HK - Hong Kong 10
AR - Argentina 9
MX - Messico 7
ID - Indonesia 4
ZA - Sudafrica 4
IQ - Iraq 3
KE - Kenya 3
SN - Senegal 3
AT - Austria 2
CL - Cile 2
CO - Colombia 2
BG - Bulgaria 1
GE - Georgia 1
IN - India 1
JO - Giordania 1
LB - Libano 1
NL - Olanda 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
RU - Federazione Russa 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 10.512
Città #
Genova 4.955
Genoa 3.358
Vado Ligure 962
Rapallo 670
Singapore 62
Ashburn 37
Ho Chi Minh City 29
Hanoi 26
Beijing 25
Bordighera 20
Tianjin 11
Hong Kong 10
Haiphong 5
Mexico City 5
Scandicci 4
Da Nang 3
Dakar 3
Hải Dương 3
Nairobi 3
Santo André 3
Duque de Caxias 2
Johannesburg 2
Juiz de Fora 2
Milan 2
Nha Trang 2
Phủ Lý 2
Praia Grande 2
Rondonópolis 2
Sarzana 2
Shanghai 2
Alterosa 1
Amman 1
Aracati 1
Assaí 1
Asunción 1
Baghdad 1
Bagé 1
Batumi 1
Belford Roxo 1
Bella Vista 1
Biên Hòa 1
Bucaramanga 1
Buenos Aires 1
Buon Ma Thuot 1
Caraíbas 1
Colorado 1
Comodoro Rivadavia 1
Concepción 1
Dianópolis 1
Erbil 1
Extrema 1
Guangzhou 1
Guarapari 1
Hermosillo 1
Hortolândia 1
Hyderabad 1
Hưng Yên 1
Irati 1
Itajubá 1
Jakarta 1
José C. Paz 1
João Pessoa 1
Jurema 1
Karachi 1
Knittelfeld 1
Kungur 1
Kyiv 1
Lago da Pedra 1
Lima 1
Linhares 1
Londrina 1
Lupionópolis 1
Lấp Vò 1
Mar de Ajó 1
Maricá 1
Medan 1
Medellín 1
Menifee 1
Midrand 1
Nam Định 1
Nantong 1
Ninh Bình 1
Olivos 1
Paulo Afonso 1
Petrópolis 1
Picos 1
Porvenir 1
Posadas 1
Puerto Madryn 1
Reggio Emilia 1
San Nicolás de los Arroyos 1
Santos 1
Shijiazhuang 1
Sorocaba 1
Surakarta 1
Suzhou 1
São José dos Campos 1
São Mateus do Sul 1
São Paulo 1
São Vicente 1
Totale 10.284
Nome #
Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. 214
Dendritic cell editing by natural killer cells. 196
A mixture of bacterial mechanical lysates is more efficient than single strain lysate and of bacterial-derived soluble products for the induction of an activating phenotype in human dendritic cells 192
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 174
T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties 171
Detection of MAGE-1, -2, and -3 messenger RNA in tissue samples derived from lung and mammary tumors. 169
Mucosal Immunology and Probiotics. 169
Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34+ myeloid precursors. 164
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 163
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 162
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 161
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 155
Novel perspectives on dendritic cell-based immunotherapy of cancer 155
Human NK cells and NK receptors 155
Characterization of human afferent lymph dendritic cells from seroma fluids. 154
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 154
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 154
Adherent neoplastic cells grown at confluence downregulate HLA class I expression and enhance their susceptibility to lysis mediated by natural killer cells. 152
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. 152
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. 150
Human dendritic cells activate resting Natural Killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. 149
IFN-alpha mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome 147
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression 144
Amniotic fluid contains multipotent mesenchymal stromal cells with high proliferative potential and safety features: solid perspectives for clinical application 142
CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells 141
Surface receptors and functional interactions of human natural killer cells: from bench to the clinic 140
Dendritic cells efficiently cross-prime HLA class I restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates. 139
CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. 136
Cross-Talks between Natural Killer Cells and Distinct Subsets of Dendritic Cells 134
Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells 134
Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens. 132
Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation. 132
Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph. 131
The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell ig-like receptors and become cytolytic. 129
Phenotypic, functional and molecular analysis of lymphocytes associated with bladder cancer. 128
Role of natural killer cells in the pathogenesis and progression of multiple sclerosis 124
Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses 124
Do NK cells play a role in the possible association between natalizumab treatment and the development of melanoma? 123
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab 123
Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. 122
Targeting ctla-4 directly on melanoma cells: A possible novel perspective in the immunotherapy of cutaneous melanoma. 119
Effector and regulatory events during natural killer-dendritic cell interactions 113
Human natural killer cell function and their interactions with dentritic cells. 113
The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFNα Production. 113
The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells 111
Cognate HLA absence in trans diminishes human NK cell education 109
Symptomatic carotid atherosclerotic plaques are associated with increased infiltration of natural killer (NK) cells and higher serum levels of NK activating receptor ligands 109
Morphological, phenotypic and karyotypic characterization of a novel natural-killer-cell target - evidence of involvement of MHC class-I molecules in NK cell recognition. 103
NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion 99
The anti-tumor activity of bacillus Calmette-Guerin in bladder cancer is associated with an increase in the circulating level of interleukin-2. 99
Natural Killer cells infiltrating human non-small cell lung cancer are enriched in CD56bright CD16- cells and display an impaired capability to kill tumor cells 98
Heterogeneity of the alpha-interferon-mediated overexpression of class-I and class-II major histocompatibility complex molecules in primary cultured cancer cells. 95
Update on natural killer cells: cross-talk with dendritic cells and role in the cure of acute myeloid leukemias. 92
NK cells at the interface between innate and adaptive immunity 92
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions. 91
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 90
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade 85
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules 84
Treatment of superficial bladder cancer with intravesical perfusion of rIL-2: a follow-up study. 81
Mechanical bacterial lysate administration prevents exacerbation in allergic asthmatic children—The EOLIA study 80
The engagement of ctla-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and tnf-alpha production. 77
Il recettore CTLA-4 è espresso dalle cellule dendritiche umane e ne regola le funzioni. 71
Mechanical bacterial lysate enhances antimicrobial barrier mechanisms in human airway epithelial cells 62
A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis 59
Cognate HLA absence diminishes human NK cell education in trans 59
An historical overview: The discovery of how NK cells can kill enemies, recruit defense troops, and more 58
Vitamin D plasma level can affect nivolumab drug exposure in a cohort of patients with non-small-cell lung cancer 56
Acquisition and presentation of tumor antigens by dendritic cells 55
A PHASE-I STUDY OF INTRAVESICAL CONTINUOUS PERFUSION OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH SUPERFICIAL BLADDER- CANCER 52
Adaptative immunotherapy of advanced solid tumors 50
Anti-Bacterial Adhesion on Abiotic and Biotic Surfaces of the Exopolysaccharide from the Marine Bacillus licheniformis B3-15 49
Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15 48
Biological parameters in breast cancer 46
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 45
Analysis of HLA-class-I specific natural killer cell receptors expressed on T lymphocytes infiltrating non-small-cell lung cancer 45
Evaluation of the canonical/non-canonical Wnt signalling pathways during oxidative stress in colorectal cancer cell line models 41
Dendritic Cell-Based Immunotherapy of Cancer: Current Pitfalls and Challenges 40
Identification of Natural Killer Cells in Tissues and Their Isolation 37
A multivariate analysis of Multiple Myeloma subtype plasma cells 37
Cytotoxic effects of high energy shock waves on cancer cells linked to metallic beads vehicled by monoclonal antibodies 36
SPONTANEOUS TRANSFORMATION AND IMMORTALIZATION OF PERITONEAL- MACROPHAGES OF HUMAN-ORIGIN 35
Interactions between natural killer and dendritic cells during bacterial infections 34
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways 34
NK cell compartments and their activation by dendritic cells 34
Biofilm Development and Approaches to Biofilm Inhibition by Exopolysaccharides 33
T cell polarizing properties of probiotic bacteria 33
Flavonoid profile, antioxidant and cytotoxic activity of different extracts from Algerian Rhamnus alaternus L. bark 32
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 32
Neutrophil-like Monocytes Increase in Patients with Colon Cancer and Induce Dysfunctional TIGIT+ NK Cells 32
Changes in plasma 5-HT levels and equine leukocyte SERT expression in response to treadmill exercise 31
Isolation and Analysis of Human Natural Killer Cell Subsets 31
FITC-labelled clone from phage display for direct detection of leukemia cells in blood 30
Clinical drug response to thiopurines is associated with a lower interferon-γ production by IBD patient’s T lymphocytes 29
EMODERIVATO IN FORMA DI GEL COMPRENDENTE FIBRINA, PIASTRINE E LEUCOCITI 29
In vivo evidence for dendritic cell lysis by NK cells: Hints on improving cancer vaccines by targeting NK cell activation 29
Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors 29
Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells 29
CLASS-I HLA AND ICAM-1 MOLECULE EXPRESSION IN PRIMARY CULTURED CANCER-CELLS DECREASES IN A STATIONARY-PHASE OF CELL-GROWTH 28
Dendritic cells generated either from CD34(+) progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8(+) T cells 28
Raman spectroscopy is able to discriminate between CD138-/CD138+ plasmacells of multiple myeloma patients 28
Totale 9.609
Categoria #
all - tutte 41.281
article - articoli 38.964
book - libri 80
conference - conferenze 1.129
curatela - curatele 0
other - altro 0
patent - brevetti 189
selected - selezionate 0
volume - volumi 919
Totale 82.562


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021303 0 0 0 0 0 43 20 34 45 51 63 47
2021/2022830 30 74 59 81 35 49 54 206 48 67 34 93
2022/2023881 72 71 15 63 112 129 3 58 130 6 211 11
2023/2024915 19 64 38 164 96 227 19 31 37 38 73 109
2024/20252.149 35 215 118 103 306 233 218 285 40 112 192 292
2025/20261.717 444 105 323 353 444 48 0 0 0 0 0 0
Totale 10.712